Pricing
ApoGlyx
Contact
No bio yet
Michael Rützler
CEO
Preben Bruun-Nyzell
Chairman Of The Board
This person is not in any teams
This person is not in any offices
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Industries
Links
Big Orange Planet
NBOUND
Yolat
Nekera
OKIN Process
View more